David Matthew Tinsider trades

In SEC Form 4 filings, David Matthew T is listed as Chief Financial Officer of Actinium Pharmaceuticals, Inc. (ATNM). David Matthew T reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 16.

Companies and roles

Company	Role	Transactions	Last filed
ATNMActinium Pharmaceuticals, Inc.	Chief Financial Officer	2	Oct 16

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-16

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
ATNMActinium Pharmaceuticals, Inc.	Oct 14	Oct 16	A	250,000	$0.00	$0	250,000	No	Form 4
ATNMActinium Pharmaceuticals, Inc.	Oct 14	Oct 16	A · derivative	250,000	$0.98	$243,750	250,000	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.